SmithKline Beecham Clinical Laboratories
This article was originally published in The Gray Sheet
Introduces a polymerase chain reaction-based chlamydia laboratory testing service. The firm is promoting the test for use by men, noting that it enables testing with urine samples "instead of the old painful method of urethral swabbing." The firm says the test will cost about $100 and will be able to provide results within 48 hours of the laboratory's receipt of a sample. The company, which licenses PCR technology from Roche, currently offers PCR laboratory testing for HIV and tuberculosis
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.